Frederic Moll is listed as a director on 3 SEC Form D filings by 2 issuers between Dec 2014 and Mar 2025: VerAvanti Inc. (Bothell, WA — industry reported as "Other" — 2025; $28.3M reported sold to 17 investors) and CEREVAST THERAPEUTICS, INC. (Redmond, WA — other health care — 2014–2015; $11.4M reported sold to 14 investors).
What this means 2 separate companies raised money with this person listed as director, over about 11 years. Across those companies the filings report $39.7M sold in total.
Listed alongside Gerald McMorrow (3 shared filings), Anthony Allenman (2 shared filings), Bradford A. Zakes (2 shared filings), Paul Clark (2 shared filings), Yuquan Wang (2 shared filings) and 6 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Frederic. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Frederic Moll and found 8 differences: Form D filed 17 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.